Premium
Clinical Endpoint Bioequivalence Studies Are Needed: A Perspective From Brand Drugs
Author(s) -
Krishna Rajesh,
Kesisoglou Filippos
Publication year - 2019
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt.1245
Subject(s) - bioequivalence , stock (firearms) , perspective (graphical) , business , drug approval , brand names , endpoint determination , pharmacology , clinical trial , medicine , marketing , computer science , drug , engineering , pharmacokinetics , artificial intelligence , mechanical engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom